LIPODYSTROPHY
Clinical trials for LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare fat disorder: drug keeps working in Long-Term study
Disease control OngoingThis study gives the drug metreleptin to people with partial lipodystrophy, a rare condition that causes abnormal fat storage, high blood fats, and diabetes. Participants have already shown improvement from metreleptin in earlier studies and cannot get the drug elsewhere. The goa…
Matched conditions: LIPODYSTROPHY
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
Lifesaving drug made available for rare fat disorder patients
Disease control OngoingThis study gives the drug metreleptin to people with generalized lipodystrophy, a rare condition that causes severe fat loss and leads to diabetes and high blood fats. Participants, aged 6 months and older, have already received metreleptin in past NIH studies but cannot get it i…
Matched conditions: LIPODYSTROPHY
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 17, 2026 02:39 UTC